Sacubitril/valsartan associated with improved renal outcomes in patients with heart failure
New medication shows potential to protect kidneys in heart failure
This meta-analysis evaluated the impact of sacubitril/valsartan compared to standard care or other agents on renal outcomes in adults with h…
A new type of heart medication may slow kidney damage for adults living with heart failure, according to a large review of patient data.
Sacubitril/Valsartan preserves left ventricular systolic function and attenuates GLS deterioration during chemotherapy
Sacubitril and Valsartan May Protect Heart Function During Chemotherapy
This meta-analysis of randomized controlled trials evaluates sacubitril/valsartan for patients undergoing chemotherapy to manage chemotherap…
A new review suggests the medication sacubitril/valsartan may help preserve heart muscle function for patients undergoing chemotherapy.
Sacubitril/valsartan shows greater LVMI regression than some antihypertensives in hypertension with remodeling
New Drug Shrinks Heart Muscle Better Than Old Options
A network meta-analysis of 851 patients with essential hypertension and cardiovascular remodeling found sacubitril/valsartan achieved greate…
A new analysis shows one specific medicine shrinks thickened heart muscle better than older blood pressure treatments, offering hope for rev…